03 · What You Need to Know
Assigning Responsibility for Randomization Sequence Generation
Why Does the Identity of the Sequence Generator Matter?
The person generating a randomization sequence determines, or implements the procedure that determines, how eligible participants will be allocated to intervention conditions.
This responsibility includes applying the specified allocation ratio, randomization method, and any restrictions such as blocking or stratification.
The individual may also have access to the complete allocation list, including assignments that have not yet been released.
That access creates a potential conflict when the same person recruits participants or decides whether they satisfy eligibility criteria.
For example, a researcher who knows that the next assignment is to an experimental intervention could consciously or unconsciously influence which participant is enrolled next.
CONSORT 2025 specifically requires reporting who generated the random allocation sequence and how it was generated. Its explanation and elaboration guidance emphasizes separating sequence generation and concealment from implementation wherever possible.
The objective is to protect the independence of treatment assignment from decisions about participant selection.
Why Is an Independent Statistician Often Preferred?
A statistician experienced in randomized trial design can help ensure that the allocation sequence is consistent with the protocol and statistical analysis plan.
Relevant decisions may include the allocation ratio, whether blocking is needed, the selection of block sizes, stratification factors, and how randomization will operate across sites.
Independence from recruitment provides an additional safeguard because the person generating the sequence does not need to use future assignments when making enrollment decisions.
For example, an independent statistician might generate a concealed allocation schedule and upload it to a secure randomization system. Recruitment personnel would receive only the assignment released for each eligible participant.
However, professional title alone does not guarantee independence or adequate concealment. A statistician who shares the complete sequence with recruiters has not protected the allocation process.
The preferable arrangement combines appropriate methodological expertise with restricted access and clearly separated responsibilities.
Can the Principal Investigator Generate the Randomization Sequence?
Yes. There is no universal methodological rule prohibiting the principal investigator from generating the allocation sequence.
The concern arises when the principal investigator also has access to future assignments while recruiting participants, interpreting eligibility criteria, or deciding enrollment order.
If the principal investigator generates the sequence but has no recruitment role, and the sequence is securely concealed from those responsible for enrollment, the arrangement may be defensible.
Similarly, a principal investigator may oversee randomization procedures without personally accessing the complete allocation list.
The important distinction is between responsibility for the randomization process and operational access to future assignments.
Researchers should not assume that being the principal investigator automatically makes someone either suitable or unsuitable for sequence generation.
What Are the Three Distinct Responsibilities in Randomization?
Randomization is often described as a single activity, but its implementation involves several distinct functions.
| Responsibility |
What the person or system does |
Principal safeguard |
| Sequence generation |
Creates the treatment allocation sequence using the specified method |
Correct, unpredictable allocation mechanism |
| Allocation concealment |
Protects future assignments until they can legitimately be released |
Prevention of foreknowledge |
| Enrollment and assignment implementation |
Confirms eligibility, enrolls participants, and obtains or releases their assignments |
Enrollment decisions completed without knowledge of upcoming allocations |
These functions may involve different people or a combination of personnel and electronic systems.
CONSORT 2025 distinguishes sequence generation, concealment, and implementation in its reporting requirements. The guidance recommends separating personnel responsible for creating and protecting the sequence from those implementing assignments.
When complete separation is impractical, investigators should explain how access to the sequence is prevented.
The separate question of who should enroll participants and assign interventions concerns the operational steps after the sequence has been prepared.
Does the Person Generating the Sequence Have to Be Blinded?
Not necessarily. The sequence generator may know the coded or actual treatment allocations while preparing the assignment schedule.
The primary requirement is that this knowledge cannot influence recruitment or treatment assignment outside the prescribed randomization mechanism.
Blinding concerns whether specified people remain unaware of treatment identity during relevant activities after allocation.
Allocation concealment concerns whether upcoming assignments remain unknown before enrollment and assignment.
These safeguards address different mechanisms of bias.
For example, a statistician may know the allocation sequence while participants and outcome assessors remain blinded. Alternatively, the sequence generator may work with treatment codes without knowing which code corresponds to the experimental intervention.
Neither arrangement automatically establishes adequate concealment. Access controls and implementation procedures remain essential.
The distinction between allocation concealment and blinding should be explicitly reflected in the protocol.
What Qualifications Should the Sequence Generator Have?
The sequence generator should understand the randomization method sufficiently to implement it accurately and recognize relevant design constraints.
For a straightforward two-arm trial, this may involve generating independent assignments according to the specified allocation probabilities.
For more complicated trials, additional expertise may be necessary. Stratified permuted-block randomization, cluster randomization, unequal allocation, minimization, and adaptive designs can require specialized programming and statistical knowledge.
The individual should also understand the importance of reproducibility, secure sequence storage, and appropriate documentation.
Using a computer does not automatically make a procedure valid. The software must implement the intended algorithm correctly, and the resulting assignments must be protected.
Where trial complexity exceeds the team's expertise, involving a qualified trial statistician or randomization specialist is preferable to improvising an allocation procedure.
Should the Sequence Generator Decide the Randomization Method?
The method should be determined through the trial's scientific and statistical planning rather than left to an individual to choose independently during implementation.
The principal investigator, trial statistician, and relevant collaborators should agree on the allocation unit, ratio, restrictions, and operational requirements before recruitment begins.
The sequence generator then implements the approved procedure.
For example, if the protocol specifies 1:1 stratified permuted-block randomization by baseline severity, the generator should not independently replace it with unrestricted simple randomization merely because the latter is easier to program.
Likewise, the generator should not alter block sizes or stratification categories after reviewing treatment-group outcomes.
Any necessary change should follow appropriate protocol governance and documentation procedures.
How Should a Randomization Sequence Be Generated?
A common approach is to use a computer-based random-number generator or a validated randomization system implementing the prespecified allocation algorithm.
The sequence should reflect the intended allocation ratio and any restrictions.
For example, simple randomization with equal probabilities can independently assign each participant to A or B with probability 0.50.
Permuted-block randomization instead generates randomized arrangements within blocks containing the intended treatment allocation numbers.
Stratified randomization may require separate sequences for each predefined stratum.
Researchers should not substitute predictable methods such as alternation, birth dates, or participant identification numbers for genuine chance allocation.
The software, algorithm, and relevant parameters should be documented sufficiently to permit methodological review and reproducibility.
However, reproducibility does not require making the active allocation list available to recruiters before the trial ends.
Should a Random Seed Be Recorded?
When pseudorandom number generation is used, recording the software environment, algorithm, and seed can help reproduce the allocation sequence under the same computational conditions.
For example, a statistician may use a documented random seed to generate the allocation schedule and retain it within restricted trial records.
However, a seed should not be disclosed to personnel who could reconstruct future assignments during recruitment.
Reproducibility and allocation concealment are compatible when generation details are securely retained and access is appropriately controlled.
Not every centralized randomization system exposes or uses a user-specified seed. In such cases, system audit records and documented validation procedures may provide the relevant reproducibility evidence.
The essential requirement is a traceable, appropriately protected allocation process rather than a universal obligation to use one particular seed-management procedure.
Who Should Have Access to the Complete Allocation List?
Access should be restricted to personnel or systems with a legitimate operational need.
In many trials, an independent statistician or centralized allocation service maintains the complete sequence. Recruiters and intervention providers receive only the assignments needed for participants already enrolled.
The exact arrangement depends on the trial design, including whether interventions are blinded and how treatment supplies or intervention schedules are prepared.
Some unblinded personnel may require access to treatment codes for operational reasons. Their responsibilities should be separated from enrollment decisions and outcome assessment where appropriate.
Researchers should establish access permissions before recruitment, rather than relying on informal assurances that staff will not inspect future assignments.
Secure storage, audit logs, and documented release procedures can help demonstrate that the allocation schedule was protected.
What If the Research Team Is Too Small to Have an Independent Statistician?
Small research teams may not have a dedicated trial statistician or independent randomization office.
That constraint does not automatically prevent a credible randomized trial, but it requires careful attention to responsibilities and access controls.
One option is to ask a qualified researcher who is not involved in recruitment to generate and securely retain the sequence.
Another is to use a secure electronic allocation system that releases assignments only after eligibility and enrollment are confirmed.
Where one person must perform several functions, the protocol should explain how the person is prevented from accessing future assignments during enrollment. A genuinely secure system can sometimes provide that separation even when staffing is limited.
Simply asking the same recruiter not to look at an accessible allocation spreadsheet is a weak safeguard.
The objective is functional independence of the assignment process, even when complete organizational separation is not feasible.
Can the Same Person Generate the Sequence and Analyze the Data?
Yes, depending on the trial's governance and blinding arrangements.
A statistician may generate the randomization sequence and later conduct the statistical analysis, provided the relevant procedures preserve trial integrity and the analysis is appropriately prespecified.
However, access to unblinded treatment information during trial conduct can create additional concerns when the statistician also makes interim decisions, advises on trial modifications, or participates in outcome-dependent analysis choices.
Some trials separate unblinded allocation or interim-analysis statisticians from the blinded trial analysis team.
The need for this separation depends on the trial's design, monitoring structure, and risk of operational bias.
The critical issue is not whether one person performs more than one technical task, but whether their access and responsibilities could compromise enrollment, trial conduct, or interpretation.
What If the Randomization Sequence Is Generated Automatically?
Automated systems can generate or implement treatment assignments without requiring a person to manually prepare an allocation list.
Nevertheless, a named person or organizational unit should remain responsible for specifying, validating, and overseeing the randomization procedure.
The system should be configured according to the protocol, tested before use, and protected against unauthorized changes.
For example, an electronic system may require recruiters to confirm eligibility before releasing an assignment. It should prevent access to future allocations and maintain records of allocation events.
Automation reduces certain opportunities for human interference but does not eliminate configuration errors, inappropriate access privileges, or procedural failures.
Researchers should document both the software-based method and the responsible personnel.
What Documentation Should the Sequence Generator Maintain?
The documentation should be sufficient to establish how the allocation sequence was produced and whether it matched the approved design.
Relevant records may include the protocol version, allocation ratio, randomization unit, restrictions, software or system used, generation date, and authorized personnel.
Where applicable, the generator may also retain the random seed, program code, validation checks, and securely stored allocation schedule.
Records should distinguish the original sequence from any approved modifications and provide an audit trail for allocation release.
These materials may be needed for monitoring, statistical review, or investigation of an allocation irregularity.
They should be retained according to applicable institutional, sponsor, ethical, and regulatory requirements while protecting participant information and future treatment assignments.
What Do CONSORT 2025 and SPIRIT 2025 Require Researchers to Report?
CONSORT 2025 distinguishes the generation of the random allocation sequence, restrictions on randomization, allocation concealment, and implementation.
Its checklist asks investigators to identify who generated the sequence and the method used, describe the concealment mechanism, and report whether enrollment and assignment personnel had access to the allocation sequence.
SPIRIT 2025 similarly addresses these responsibilities during protocol development so that the allocation process can be planned before the trial begins.
These guidelines do not establish that every trial must hire an external statistician. They emphasize transparent responsibility and protection against foreknowledge.
A useful protocol should explain not only who generated the sequence but also who could access it and when assignments became available.
This makes the allocation procedure assessable rather than leaving readers to infer its integrity from the word randomized.
What Should Happen if a Sequence-Generation Error Is Discovered?
If the allocation sequence does not match the approved protocol, the research team should document the error and determine its scope before taking corrective action.
For example, the wrong allocation ratio may have been programmed, a stratification variable may have been omitted, or a sequence may have been inadvertently exposed.
The response depends on whether recruitment has begun, whether participants have received interventions, and whether the error affects participant safety or the validity of the treatment comparison.
Appropriate statistical, trial governance, and ethics personnel should be consulted as necessary.
Researchers should not silently replace assignments already implemented or generate a new sequence merely because the resulting groups appear imbalanced.
When modifications are required, they should be documented and incorporated into the protocol and analysis plan as appropriate.
